iTeos Therapeutics, Inc. (ITOS)
10.15
+0.02 (0.20%)
Inactive · Last trade price on Aug 28, 2025
iTeos Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for iTeos Therapeutics stock had an average target of 10.4, with a low estimate of 8.00 and a high estimate of 12.
Price Target: $10.4 (+2.46%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 7, 2025.
Analyst Ratings
The average analyst rating for iTeos Therapeutics stock from 6 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +8.37% | Aug 7, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $13 → $12 | Buy → Hold | Downgrades | $13 → $12 | +18.23% | May 28, 2025 |
| Wedbush | Wedbush | Buy → Hold Downgrades $10 → $12 | Buy → Hold | Downgrades | $10 → $12 | +18.23% | May 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +18.23% | May 14, 2025 |
Financial Forecast
Revenue This Year
n/a
from 35.00M
Revenue Next Year
6.88M
EPS This Year
-3.58
from -3.32
EPS Next Year
-2.08
from -3.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 35.4M | |||
| Avg | n/a | 6.9M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.98 | -0.33 | |||
| Avg | -3.58 | -2.08 | |||
| Low | -4.39 | -3.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.